Qiagen NV

Organisation

Hulsterweg 82, Venlo, Netherlands, 5912 PL

Headquarters

5700

Employees

Health Technology

Industry

Thierry Bernard

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, such as assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables, such as short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments; bioinformatics solutions; and custom laboratory and genomic services. The company provides software-as-a-service. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Price

Target

Qiagen NV (QGEN) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Qiagen NV (QGEN) share price will touch around $55.23 in next 12-months.

Currently 25 wall-street analysts regularly analyze the financials of Qiagen NV on a frequent basis to provide recommendations along with target share price. 25 analysts offering 12-month price forecasts for Qiagen NV (QGEN) have a share price target of $55.23. This median of share price forecast represents a 36.04% upside from the latest price of $40.6 as on 15.03.26.

Qiagen NV (QGEN) Share Price Forecast

Home

US Stocks

Qiagen NV (QGEN)

Qiagen NV Stock Forecast

Qiagen NV Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Qiagen NV (QGEN): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Qiagen NV's share price and its median forecast price. As on 15.03.26, the difference is -6.39%

Qiagen NV Forecast and Target Price

Qiagen NV (QGEN) Share Price Forecast

Qiagen NV (QGEN) Price vs Consensus Price Target

Qiagen NV (QGEN) Share Price Forecast v/s Share Price Today

Qiagen NV (QGEN): Difference between Current Price & Median Forecasted Price

Qiagen NV (QGEN) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price